Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer

Published:2011-05 Issue:5 Volume:6 Page:920-926
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Kozak Margaret M.,Murphy James D.,Schipper Meike L.,Donington Jessica S.,Zhou Lisa,Whyte Richard I.,Shrager Joseph B.,Hoang Chuong D.,Bazan Jose,Maxim Peter G.,Graves Edward E.,Diehn Maximilian,Hara Wendy Y.,Quon Andrew,Le Quynh-Thu,Wakelee Heather A.,Loo Billy W.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 10 [Internet];Ferlay,2010

3. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

4. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer;van Meerbeeck;J Natl Cancer Inst,2007

5. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial;Albain;Lancet,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy;International Journal of Clinical Oncology;2023-11-30

2. Significance of the cytokeratin-19 fragment and CXCR1, CXCR2 receptors in the blood for prediction of the relapse-free survival of patients with stage III non-small cell lung cancer;Proceedings of the National Academy of Sciences of Belarus, Medical series;2023-06-05

3. Radiomics in the Setting of Neoadjuvant Radiotherapy: A New Approach for Tailored Treatment;Cancers;2021-07-17

4. Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysis;Radiotherapy and Oncology;2020-10

5. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy;Journal of Thoracic Oncology;2020-05